Technical Analysis for SIBN - SI-BONE, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 20 DMA Resistance | Bearish | -2.62% | |
| Fell Below 50 DMA | Bearish | -2.62% | |
| Outside Day | Range Expansion | -2.62% | |
| Wide Bands | Range Expansion | -2.62% | |
| 20 DMA Resistance | Bearish | -3.98% | |
| Crossed Above 50 DMA | Bullish | -3.98% | |
| MACD Bullish Signal Line Cross | Bullish | -3.98% |
| Alert | Time |
|---|---|
| Possible NR7 | about 9 hours ago |
| Down 3% | about 14 hours ago |
| Fell Below Previous Day's Low | about 14 hours ago |
| Down 2 % | about 14 hours ago |
| Down 1% | about 14 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/12/2024
SI-BONE, Inc. Description
SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Dysfunction Prosthetics Implant Quality Of Life Minimally Invasive Procedure Pelvis Surgical Treatment Joint Dysfunction Medical Classification Sacroiliac Joint
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.64 |
| 52 Week Low | 11.7 |
| Average Volume | 395,746 |
| 200-Day Moving Average | 14.75 |
| 50-Day Moving Average | 13.44 |
| 20-Day Moving Average | 13.60 |
| 10-Day Moving Average | 12.82 |
| Average True Range | 0.72 |
| RSI (14) | 47.09 |
| ADX | 18.7 |
| +DI | 20.76 |
| -DI | 22.39 |
| Chandelier Exit (Long, 3 ATRs) | 14.02 |
| Chandelier Exit (Short, 3 ATRs) | 13.86 |
| Upper Bollinger Bands | 16.25 |
| Lower Bollinger Band | 10.95 |
| Percent B (%b) | 0.39 |
| BandWidth | 38.99 |
| MACD Line | -0.19 |
| MACD Signal Line | -0.22 |
| MACD Histogram | 0.0285 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 13.50 | ||||
| Resistance 3 (R3) | 13.52 | 13.38 | 13.42 | ||
| Resistance 2 (R2) | 13.38 | 13.26 | 13.37 | 13.39 | |
| Resistance 1 (R1) | 13.20 | 13.18 | 13.13 | 13.18 | 13.37 |
| Pivot Point | 13.06 | 13.06 | 13.03 | 13.05 | 13.06 |
| Support 1 (S1) | 12.88 | 12.94 | 12.81 | 12.86 | 12.67 |
| Support 2 (S2) | 12.74 | 12.86 | 12.73 | 12.65 | |
| Support 3 (S3) | 12.56 | 12.74 | 12.62 | ||
| Support 4 (S4) | 12.54 |
